So despite the success of HIV drugs and PrEP, precarious health-care systems and high drug costs mean we can't rely on them ...

The elimination of the latent viral reservoir remains the main barrier in the quest for a cure for people with HIV (PWH). The administration of latency reversal agents (LRA) at antiretroviral ...

In the ongoing fight against HIV, scientists have taken a new step toward long-term control of the virus. Researchers have ...

The global hunt for an HIV cure remains a puzzle, despite nearly 40 years of research and progress in treatment and prevention. Scientists have struggled largely because of the virus's ability ...

How will the Trump administration's cuts to HIV research impact the progress that's been made towards ending the epidemic in the U.S.?

In early 2025, the US decision to halt foreign aid for HIV/AIDS programs triggered global concerns about a potential ...

When it comes to a clinical study to evaluate the therapeutic effect of Shivagutika treatment in patients with HIV, it was ...

This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.

The drug, in June, received FDA approval as the first twice-yearly pre-exposure prophylaxis (PrEP) option to reduce the risk ...

More treatment facilities have been established in Eastern Visayas in response to the rising number of human immunodeficiency ...

In a report released on Thursday, the UN body in charge of fighting HIV/Aids does not single out the US, but says that ...